Physician profile
Donald Holzer
NPI 1295727105
$13,061.60
in general payments reported to CMS, 2019-2025
47 companies · $1,884 in 2025
The $1,884 reported for 2025 was more than what 77% of Pain Medicine (Psychiatry & Neurology) providers received nationally (typical 2025 total: $405).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,575 · 2020: $1,494 · 2021: $1,913 · 2022: $2,006 · 2023: $2,317 · 2024: $1,872 · 2025: $1,884.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,073.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,072.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,333.18 | 2021-2025 | |
| Lundbeck LLC | $2,021.04 | 2020-2025 | Vyepti |
| Collegium Pharmaceutical, INC. | $1,261.79 | 2019-2025 | Xtampza, Belbuca |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $969.06 | 2020-2025 | Relistor |
| Amgen INC. | $846.87 | 2019-2022 | |
| Pfizer INC. | $715.03 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $609.15 | 2019-2021 | |
| Allergan, INC. | $470.05 | 2019-2022 | |
| Lilly USA, LLC | $335.10 | 2019-2025 | Emgality, Reyvow |
| Takeda Pharmaceuticals U.S.A., INC. | $318.14 | 2019-2023 | Trintellix |
| Teva Pharmaceuticals USA, INC. | $276.65 | 2019-2022 | |
| Biohaven Pharmaceutical Holding Company Ltd. | $268.69 | 2022 | |
| Scilex Pharmaceuticals INC. | $256.69 | 2019-2024 | Ztlido |
| Arbor Pharmaceuticals, INC. | $212.59 | 2020-2022 | |
| Vertex Pharmaceuticals Incorporated | $170.82 | 2024-2025 |
Show all 47 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Donald Holzer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.